Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN112876427B reveals a greener Acesulfame K route eliminating SO3 and triethylamine, offering significant cost reduction and yield improvement for sweetener manufacturers.
Novel patent CN110128347A enables high-purity indazole intermediate production with scalable carbonylation technology for reliable pharmaceutical supply chains.
Patent CN1526711A details a scalable Reformatsky process for Gemcitabine intermediates, offering high stereoselectivity and cost reduction in pharmaceutical manufacturing.
Patent CN104672189A details Ru-catalyzed asymmetric hydrogen transfer for high-purity chiral alcohols. Offers significant cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Patent CN113735752A reveals a novel metal-free route for S-aryl isothiourea synthesis, offering significant cost reduction and simplified supply chains for API manufacturing.
Patent CN111072555A details a green HEH-catalyzed method for heterocyclic sulfones, offering cost reduction and supply chain reliability for pharma intermediates.
Patent CN114656494B reveals a novel chitosan copper catalyst for allyl borate synthesis, offering cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN116730905B reveals Pd-catalyzed carbonylation for spiroindoline. Offers cost reduction and supply chain reliability for high-purity pharmaceutical intermediate manufacturing.
Novel copper-catalyzed method for 3,5-dichloroaniline. Reduces cost and environmental impact. Reliable supply for agrochemical intermediates.
Patent CN113968815B reveals a novel apalutamide intermediate synthesis route offering high purity and cost reduction for pharmaceutical manufacturing supply chains.
Novel two-step synthesis for Vonoprazan fumarate intermediate offers high purity and cost efficiency. Reliable supply chain solution for pharmaceutical intermediates manufacturing globally.
Patent CN105085275A introduces a green ortho-nitration method. Enhance supply chain reliability and reduce purification costs with high-selectivity pharma intermediates.
Patent CN104910079B reveals efficient one-pot oxidation for 4(3H)-quinazolinone derivatives. Offers cost reduction and scalable manufacturing for pharmaceutical intermediates.
Novel copper-catalyzed route for 6-methylphenanthridine synthesis offers mild conditions and environmental safety, ensuring reliable supply chain stability and cost efficiency for pharmaceutical manufacturing.
Novel copper-catalyzed synthesis of 3 5-dichloroaniline offers cost reduction and supply chain reliability for agrochemical intermediate manufacturing globally.
Patent CN111253271B reveals a continuous flow method for methyl 2-amino-3-nitrobenzoate, enhancing safety and yield for ARB drug intermediates.
Patent CN106008492B reveals a palladium-free Razaxaban synthesis route offering high purity and cost reduction for pharmaceutical intermediate supply chains.
Advanced melt crystallization patent CN107266294A ensures 99.5% purity. Reduces energy consumption and improves supply chain reliability for global buyers.
Patent CN110386885A enables metal-free visible light synthesis of β-carbonyl sulfones. Achieve cost reduction in fine chemical manufacturing with scalable, green protocols.
Patent CN103254075A reveals a novel synthesis for Flurbiprofen Axetil achieving >99% purity. Discover cost-effective manufacturing and reliable supply chain solutions.